The emerging role of ACE2 in physiology and diseaseHAMMING, I; COOPER, M. E; HAAGMANS, B. L et al.Journal of pathology. 2007, Vol 212, Num 1, pp 1-11, issn 0022-3417, 11 p.Article

Virus specific immune responses after human neoadjuvant adenovirus-mediated suicide gene therapy for prostate cancerVAN DER LINDEN, R. R. M; HAAGMANS, B. L; MONGIAT-ARTUS, P et al.European urology. 2005, Vol 48, Num 1, pp 153-161, issn 0302-2838, 9 p.Article

Foreign-body reaction to dermal sheep collagen in interferon-γ-receptor knock-out miceKHOUW, I. M. S. L; VAN WACHEM, P. B; PLANTINGA, J. A et al.Journal of biomedical materials research. 2000, Vol 50, Num 2, pp 259-266, issn 0021-9304Article

Suppression of rat cytomegalovirus replication by antibodies against gamma inteferonHAAGMANS, B. L; VAN DER MEIDE, P. H; STALS, F. S et al.Journal of virology. 1994, Vol 68, Num 4, pp 2305-2312, issn 0022-538XArticle

Protection of rats against pseudorabies virus infection by γ-interferonSCHIJNS, V. E. C; HAAGMANS, B. L; SCHELLEKENS, H et al.Proceedings of the Society for Experimental Biology and Medicine. 1989, Vol 192, Num 1, pp 47-55, issn 0037-9727, 9 p.Article

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infectionsCORMAN, V. M; MÜLLER, M. A; BLEICKER, T et al.Euro surveillance. 2013, Num JUL, pp 36-44, issn 1025-496X, 9 p., NS2Article

Vaccination of pigs against pseudorabies virus with plasmid DNA encoding glycoprotein DHAAGMANS, B. L; VAN ROOIJ, E. M. A; DUBELAAR, M et al.Vaccine. 1999, Vol 17, Num 9-10, pp 1264-1271, issn 0264-410XArticle

Tumour necrosis factor-α, interferon-γ and interferon-β exert antiviral activity in nervous tissue cellsSCHIJNS, V. E. C. J; VAN DER NEUT, R; HAAGMANS, B. L et al.Journal of general virology. 1991, Vol 72, Num 4, pp 809-815, issn 0022-1317Article

ALT and viral load decline during PEG-IFN alpha-2b treatment for HBeAg-positive chronic hepatitis BTER BORG, M. J; HANSEN, B. E; BIGOT, G et al.Journal of clinical virology. 2008, Vol 42, Num 2, pp 160-164, issn 1386-6532, 5 p.Article

Tumour necrosis factor-α production during cytomegalovirus infection in immunosuppressed ratsHAAGMANS, B. L; VAN DEN EERTWEGH, A. J. M; CLAASSEN, E et al.Journal of general virology. 1994, Vol 75, pp 779-787, issn 0022-1317, 4Article

Tumor necrosis factor α levels in cats experimentally infected with feline immunodeficiency virus : effects of immunization and feline leukemia virus infectionLEHMANN, R; JOLLER, H; HAAGMANS, B. L et al.Veterinary immunology and immunopathology. 1992, Vol 35, Num 1-2, pp 61-69, issn 0165-2427Conference Paper

Differential antiviral effect of PEG-interferon-α-2b on HIV and HCV in the treatment of HIV/HCV co-infected patientsNEUMANN, A. U; POLIS, M. A; KOTTILIL, Shyam et al.AIDS (London). 2007, Vol 21, Num 14, pp 1855-1865, issn 0269-9370, 11 p.Article

Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')₂ fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzeesVAN DER POLL, T; LEVI, M; TEN CATE, H et al.Clinical and experimental immunology (Print). 1995, Vol 100, Num 1, pp 21-25, issn 0009-9104Article

Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzeesVAN DER POLL, T; LEVI, M; VAN DEVENTER, S. J. H et al.Blood. 1994, Vol 83, Num 2, pp 446-451, issn 0006-4971Article

Tumor necrosis factor alpha promotes replication and pathogenicity of rat cytomegalovirusHAAGMANS, B. L; STALS, F. S; VAN DER MEIDE, P. H et al.Journal of virology. 1994, Vol 68, Num 4, pp 2297-2304, issn 0022-538XArticle